Pathogenesis and Diagnosis of Psoriatic Arthritis

Lisa Anggriani Susanto, Arief Nurudhin

Abstract

Introduction: Psoriatic arthritis (PsA) is a chronic, heterogeneous inflammatory disease closely associated with psoriasis of the skin and nails. Its clinical manifestations are diverse, involving peripheral joints, the axial skeleton, entheses (sites where tendons or ligaments attach to bone), and various extra-articular sites, making its diagnosis a significant clinical challenge.

Methods: This is a narrative review of recent literature focusing on the complex pathogenesis and evolving diagnostic strategies for PsA. The review synthesizes information on genetic, immunological, and environmental factors, as well as the role of modern imaging and laboratory findings in accurate diagnosis.

Results: The pathogenesis of PsA arises from a complex interplay of genetic predisposition (such as HLA-B27), immunological pathways, and environmental triggers like mechanical stress and infections. The activation of both the innate and adaptive immune systems, particularly the IL-23/IL-17 axis, is central to driving the chronic inflammation and joint damage characteristic of the disease. Diagnosing PsA is often difficult due to its overlapping features with other inflammatory arthritides. The Classification Criteria for Psoriatic Arthritis (CASPAR) are widely used and incorporate evidence of psoriasis, specific patterns of joint involvement, dactylitis, and characteristic radiological changes. Imaging modalities are crucial for an early and accurate diagnosis: conventional radiography detects classic erosions and new bone formation, ultrasonography is sensitive for evaluating synovitis and enthesitis, and MRI is excellent for identifying early inflammatory changes in both axial and peripheral joints. Laboratory tests, such as a negative rheumatoid factor and anti-CCP, are key to differentiating PsA from rheumatoid arthritis.

Conclusions: A comprehensive understanding of the pathogenesis and diagnostic strategies for PsA is essential for early recognition, which is critical for preventing disease progression and selecting the most appropriate therapy. This review highlights current insights that can serve as a foundation for improved clinical practice in managing this complex disease.

Keywords

Psoriatic Arthritis; Pathogenesis; Diagnosis; CASPAR; Inflammation

Full Text:

PDF

References

Ritchlin CT, Colbert RA, Gladman DD. Psoriatic arthritis. N Engl J Med. 2017;376(10):957-70.

Perez-Chada LM, Merola JF. Comorbidities associated with psoriatic arthritis: review and update. Clin Immunol. 2020;214:108397.

Coates LC, Helliwell PS. Psoriatic arthritis: state of the art review. Clin Med (Lond). 2017;17(1):65-70.

Azuaga AB, Ramírez J, Cañete JD. Psoriatic arthritis: pathogenesis and targeted therapies. Int J Mol Sci. 2023;24(5):4901.

FitzGerald O, Ogdie A, Chandran V, Coates LC, Kavanaugh A, et al. Psoriatic arthritis. Nat Rev Dis Primers. 2021;7(1):59.

Villani AP, Rouzaud M, Sevrain M, Barnetche T, Paul C, Richard MA, et al. Prevalence of undiagnosed psoriatic arthritis among psoriasis patients: systematic review and meta-analysis. J Am Acad Dermatol. 2015;73(2):242-8.

Eder L, Haddad A, Rosen CF, Lee KA, Chandran V, Cook R, et al. The incidence and risk factors for psoriatic arthritis in patients with psoriasis: a prospective cohort study. Arthritis Rheumatol. 2016;68(4):915-23.

Scher JU, Ogdie A, Merola JF, Ritchlin C. Preventing psoriatic arthritis: focusing on patients with psoriasis at increased risk of transition. Nat Rev Rheumatol. 2019;15(3):153-66.

Gupta S, Syrimi Z, Hughes DM, Zhao SS. Comorbidities in psoriatic arthritis: a systematic review and meta-analysis. Rheumatol Int. 2021;41(2):275-84.

Schett G, Rahman P, Ritchlin C, McInnes IB, Elewaut D, Scher JU. Psoriatic arthritis from a mechanistic perspective. Nat Rev Rheumatol. 2022;18(6):311-25.

Bowes J, Budu-Aggrey A, Huffmeier U, Uebe S, Steel K, Hebert HL, et al. Dense genotyping of immune-related susceptibility loci reveals new insights into the genetics of psoriatic arthritis. Nat Commun. 2015;6:6046.

Schett G, Lories RJ, D'Agostino MA, Elewaut D, Kirkham B, Soriano ER, et al. Enthesitis: from pathophysiology to treatment. Nat Rev Rheumatol. 2017;13(12):731-41.

Jadon DR, Stober C, Pennington SR, FitzGerald O. Applying precision medicine to unmet clinical needs in psoriatic disease. Nat Rev Rheumatol. 2020;16(11):609-27.

Coates LC, Moverley AR, McParland L, Brown S, Navarro-Coy N, O'Dwyer JL, et al. Effect of tight control of inflammation in early psoriatic arthritis (TICOPA): a UK multicentre, open-label, randomised controlled trial. Lancet. 2015;386(10012):2489-97.

Imboden J, Hellmann DB, Stone JH. Current diagnosis & treatment: rheumatology. 4th ed. New York: McGraw-Hill Education; 2018.

Refbacks

  • There are currently no refbacks.